menu
    • menu

    Company profile for Regenxbio

    NEW Drugs in Dev: 8
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting e...
    REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RegenxbioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9600 Blackwell Road, Suite 210, Rockville, MD 20850
    Telephone
    Telephone
    240.552.8181
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regenxbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Regenxbio Hits Duchenne Milestone, Eyes 2027 FDA Approval
    Regenxbio Hits Duchenne Milestone, Eyes 2027 FDA Approval

    14 May 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/regenxbio-slumps-after-serious-side-effects-mar-Duchenne-gene therapy-results

    BIOSPACE
    14 May 2026
    Share Share
    REGENXBIO to Present at ASGCT 2026 Annual Meeting
    REGENXBIO to Present at ASGCT 2026 Annual Meeting

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-announces-presentations-at-the-american-society-of-gene--cell-therapy-2026-annual-meeting-302765129.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Gene Therapy's Evidence Problem—Lessons From Recent FDA Decisions
    Gene Therapy's Evidence Problem—Lessons From Recent FDA Decisions

    04 May 2026

    // BIOSPACE

    https://www.biospace.com/fda/opinion-gene-therapys-evidence-problem-lessons-from-recent-fda-decisions

    BIOSPACE
    04 May 2026
    Share Share
    Rosen Law Urges NASDAQ:RGNX Investors with Losses to Contact Firm
    Rosen Law Urges NASDAQ:RGNX Investors with Losses to Contact Firm

    14 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-14/rgnx-deadline-today-rosen-law-firm-urges-regenxbio-inc-nasdaq-rgnx-stockholders-with-large-los

    PHARMIWEB
    14 Apr 2026
    Share Share
    RGNX Stockholders: Contact Robbins LLP for Class Action
    RGNX Stockholders: Contact Robbins LLP for Class Action

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/regenxbio-inc-stockholders-should-contact-robbins-llp-for-information-about-leading-the-rgnx-class

    PHARMIWEB
    19 Mar 2026
    Share Share
    Denali’s Hunter Syndrome Drug Gains Focus After REGENXBIO Setback
    Denali’s Hunter Syndrome Drug Gains Focus After REGENXBIO Setback

    16 Mar 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/denalis-hunter-syndrome-candidate-in-the-spotlight-after-regenxbio-rejection

    BIOSPACE
    16 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search